White van with QuickSTAT logo on side

Loading iFrame

A QuickSTAT team member highlights our focus: to deliver patient therapies on time and in temperature

Getting time- and temperature-sensitive cell and gene therapies to patients is more than critical—it can be life-saving. Here’s how QuickSTAT’s 24/7 services deliver.

Loading iFrame

We care about our clients and we’ll do whatever it takes.

QuickSTAT’s Kathy Gerson’s quote captures our commitment to our clients. And as the cell and gene therapy market continues to grow and evolve, we need to evolve with it. That may bring new logistics challenges—and QuickSTAT will be prepared to overcome them.

Loading iFrame

The QuickSTAT team says "thank you!"

A “thank you!” message from the QuickSTAT team to clients who joined a June 2025 gathering of thought leaders in the advanced therapies’ community.

Loading iFrame

Learn more about QuickSTAT’s specialized cell & gene therapy logistics solutions

Bringing new cell and gene therapies to market can be complicated. Find out how QuickSTAT can help optimize logistics supply chains.

Loading iFrame

QuickSTAT celebrates Advanced Therapies Week

QuickSTAT’s Michael Sweeney explains why Advanced Therapies Weeks is so critical as the cell and gene therapy industry grows and changes.

Loading iFrame

Find out what QuickSTAT’s urgent organ and tissue donation and testing logistics solutions delivers

Whether for life-changing medical procedures or critical research – QuickSTAT’s Donation & Testing Logistics solutions deliver.

Loading iFrame

Logistics solutions for bringing new therapies to market

Matthieu Brand, Scott Ohanesian and Micheal Sweeney discuss how QuickSTAT helps deliver supply chain success for pharma and life science companies.

Loading iFrame

How we plan for the unexpected

QuickSTAT has the knowledge, technology, agility and solutions when the unexpected happens.

Loading iFrame

QuickOnline 2.0 makes the difference

QuickSTAT’s Chris Watkins highlights what our logistics platform can deliver—from submitting online orders to GPS tracking, tilt alerts and more.

Loading iFrame

What's driving the growth of clinical trials in Australia

One of QuickSTAT's thought leaders, Greg Walters, shares insights on what's driving the growth of clinical trials in Australia.

Loading iFrame

Unique experiences set QuickSTAT apart

Monroe Burgess, our Global Head of Commercial Product, shares how his team’s unique experiences set QuickSTAT apart.

Loading iFrame

QuickSTAT role in the transplant logistics process

Christopher Watkins shares the significance of his and the team’s role in the transplant logistics process.

Loading iFrame

Commitment to the APAC market

Singapore-based Melissa Goh and Richard Senior provide their thoughts on the “QuickSTAT Difference” —and commitment to the APAC market.

Loading iFrame

Ireland's role as a global pharma leader

Exploring the COVID-created rise of DTP clinical trials, Ireland's role as a global pharma leader and QuickSTAT's commitment to the market.

Loading iFrame

Putting our clinical trial logistics expertise to work for you

Hear Jay Dexheimer, Neil Peirson and John Sabo discuss how our logistics expertise delivers for our customers and their patients.

Loading iFrame

From QuickSTAT customer to donation and testing logistics expert

Chris Watkins is a 20+ year industry veteran and the father of a tissue recipient. Here he shares QuickSTAT’s role in the donation process and how it all impacts the end goal of the donor recipient and donor family.

Loading iFrame

Learn more about the Global Clinical Supplies Group: GCSG

Michael Sweeney, QuickSTAT’s Global Head of Strategy, CGT & DTP, shares his thoughts about the GCSG organization and its role as an important educational and networking event.

Loading Video

Webinar: Commercialization strategies for cell and gene therapies

The life-changing potential of CGTs is palpable—however, they are not without their complexities and challenges. Join CGT industry experts for an insightful discussion on real-world commercialization challenges and mitigation strategies.

Download transcript